Assessing Value: Promise & Pitfalls

Washington, DC

The Liaison Capitol Hill
415 New Jersey Ave., NW
Metropolitan Ballroom (Lobby Level)
Washington, DC 20001
9:00 AM - 4:00 PM ET
 

 

Value assessment frameworks are a new and evolving field, and have the potential to have a tremendous impact on patient treatment decisions, as well as on coverage and reimbursement decisions. These frameworks emerged in the U.S. in response to multiple factors, including an increased focus on patient-centered care, alternative payment models intended to incentivize health care value, and public attention on new high-priced therapies.

>> Watch the event archive via Livestream.

Related materials:

Overview

While the current value assessment frameworks have much to teach us, initial comparisons of these frameworks highlight the important differences and analytic challenges that still remain. Continued improvements are necessary to address the different perspectives inherent in assessing value.

During the conference, we shared research that evaluated how existing frameworks align with NPC’s Guiding Practices for Patient-Centered Value Assessment and explored the variable outputs from multiple myeloma treatment assessments conducted using four different frameworks. A broad range of stakeholders shared their perspectives on the research, uncovering the lessons learned to date, and how best to advance the field of value assessment.

Follow the event on Twitter using #npcvalueconf and NPC at @npcnow.

Agenda

AGENDA

8:30 am
Continental Breakfast and Registration Open

9:00 am
Welcome & Opening Comments

  • Dan Leonard, MA, President, National Pharmaceutical Council (NPC)

9:15 am
Framing the Discussion: Why Assessing Value Is Important and Why It’s Important to Do It Right

9:45 am
Presentation of Research: Moving Value Frameworks from Fledgling to Functional

  • Cliff Goodman, PhD, Senior Vice President and Director, Center for Comparative Effectiveness Research, Lewin Group

10:15 am
Break

10:30 am
Panel Discussion: Moving Value Frameworks from Fledgling to Functional

  • Moderator: Cliff Goodman, PhD, Senior Vice President and Director, Center for Comparative Effectiveness Research, Lewin Group
  • Peter J. Neumann, ScD, Director, Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center; Professor of Medicine, Tufts University School of Medicine
  • Josh Ofman, MD, MSHS, Senior Vice President, Global Value, Access & Policy, Amgen
  • Eleanor M. Perfetto, PhD, MS, Senior Vice President, Strategic Initiatives, National Health Council
  • Michael Sherman, MD, MBA, MS, Senior Vice President and Chief Medical Officer, Harvard Pilgrim Health Care

11:45 am
Lunch

12:30 pm
Presentation of Research: Why Four Frameworks (Should) Arrive at Different Conclusions: A Case Study of Multiple Myeloma Reviews

  • Cliff Goodman, PhD, Senior Vice President and Director, Center for Comparative Effectiveness Research, Lewin Group

1:00 pm
Break

1:10 pm
Framework Developers Panel Discussion: Why Four Frameworks (Should) Arrive at Different Conclusions: A Case Study of Multiple Myeloma Reviews

  • Moderator: Cliff Goodman, PhD, Senior Vice President and Director, Center for Comparative Effectiveness Research, Lewin Group
  • Robert (Bob) W. Carlson, MD, Chief Executive Officer, National Comprehensive Cancer Network
  • Anna Kaltenboeck, Program Director and Senior Health Economist, Center of Health Policy Outcomes, Memorial Sloan Kettering Cancer Center
  • Steven (Steve) D. Pearson, MD, MSc, Founder and President, Institute for Clinical and Economic Review
  • Lowell E. Schnipper, MD, Theodore and Evelyn Berenson Professor of Medicine, Harvard Medical School and Clinical Director, Cancer Center, Chief, Hematology-Oncology Division, Beth Israel Deaconess Medical Center

2:20 pm
Break

2:30 pm
Stakeholders Panel Discussion: Why Four Frameworks (Should) Arrive at Different Conclusions: A Case Study of Multiple Myeloma Reviews

  • Moderator: Robert (Bobby) W. Dubois, MD, PhD, Executive Vice President & Chief Science Officer, NPC
  • Roy Beveridge, MD, Chief Medical Officer, Humana
  • Gwen Darien, Executive Vice President for Patient Advocacy, National Patient Advocate Foundation
  • Shelley Fuld Nasso, MPP, Chief Executive Officer, National Coalition for Cancer Survivorship
  • Stephen J. Noga, MD, PhD, Senior Medical Director for Global Medical Affairs, Takeda Oncology

3:40 pm
Closing Remarks

  • Robert (Bobby) W. Dubois, MD, PhD, Executive Vice President & Chief Science Officer, NPC
  • Cliff Goodman, PhD, Senior Vice President and Director, Center for Comparative Effectiveness Research, Lewin Group

4:00 pm 
Adjourn

Contact

Questions? Contact:
Tanya Bailey
Membership & Meetings Associate
202-827-2092
tbailey@npcnow.org

 

Sessions

Caregiver Action Network
 
 
 
Global Liver Institute
 
 
 
National Black Nurses Association
 
 
 

 
 
 
National Psoriasis Foundation